LU; I-Huang

Patent Applications and Registrations

Patent applications and USPTO patent grants for LU; I-Huang.The latest application filed is for "pharmaceutical formulations for a liquid dosage form and a controlled release dosage form".

Company Profile

3.3.7

LU; I-Huang - Hsinchu City TW
Lu; I-Huang - Hsinchu TW
Lu; I-Huang - Taipei TW
LU; I-Huang - Taipei City TW
LU; I-Huang - Zhudong Township TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Formulations For A Liquid Dosage Form And A Controlled Release Dosage Form App 20220249395 - HUANG; Kuo-Kuei ; et al.	2022-08-11
Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form Grant 11,400,054 - Huang , et al. August 2, 2	2022-08-02
Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis App 20210015882 - HUANG; Kuo-Kuei ; et al.	2021-01-21
Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis Grant 10,821,148 - Huang , et al. November 3, 2	2020-11-03
Method For Treating An Autoimmune Neurological Disease And/or Neurodegenerative Disease And Pharmaceutical Formulations For A Liquid Dosage Form And A Controlled Release Dosage Form App 20190000776 - HUANG; Kuo-Kuei ; et al.	2019-01-03
Pharmaceutical Composition For Treating Or Alleviating An Autoimmune Disease And/or Complication Thereof And/or Nephritis And Method For Treating Or Alleviating An Autoimmune Disease And/or Complication Thereof And/or Nephritis App 20170258865 - HUANG; Kuo-Kuei ; et al.	2017-09-14
Method for modulating Th17 cells and method for treating a disease related to modulation of Th17 cells Grant 9,603,882 - Pan , et al. March 28, 2	2017-03-28
Pharmaceutical Compositions For Inhibiting Angiogenesis App 20160008319 - PAN; I-Horng ; et al.	2016-01-14
Method For Modulating Th17 Cells And Method For Treating A Disease Related To Modulation Of Th17 Cells App 20150050315 - PAN; I-Horng ; et al.	2015-02-19
Pharmaceutical Compositions And Method For Inhibiting Angiogenesis App 20140170250 - PAN; I-Horng ; et al.	2014-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.